Načítá se...

Pharmacokinetic and pharmacodynamic modeling of sarafloxacin against avian pathogenic Escherichia coli in Muscovy ducks

BACKGROUND: This study focused on utilizing pharmacokinetics/pharmacodynamics (PK/PD) modeling to optimize therapeutic dosage regimens of sarafloxacin against avian pathogenic Escherichia. coli O78 strain in Muscovy ducks. The ex vivo PK/PD study of sarafloxacin was conducted in Muscovy ducks after...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Vet Res
Hlavní autoři: Yu, Yang, Zhou, Yu Feng, Sun, Jian, Shi, Wei, Liao, Xiao Ping, Liu, Ya Hong
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5301423/
https://ncbi.nlm.nih.gov/pubmed/28183350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12917-017-0964-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!